Sarcoidosis after use of interferon for chronic hepatitis C: Report of a case and review of the literature

Digestive Diseases and Sciences

Volumn 48, Issue 1, 2003, Pages 169-173

  Tahan, Veysel ^a,f   Ozseker, F ^b   Guneylioglu, D ^b   Baran, A ^b   Ozaras, R ^c   Mert, A ^c   Ucisik, A C ^d   Cagatay, T ^e   Yilmazbayhan, D ^c   Senturk, H ^c  

^a MARMARA UNIVERSITY   (Turkey)

^b SSK Sureyyapasa Center   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Gostepe Training and Research Hospital   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f NONE   (Turkey)

Author keywords

Chronic hepatitis C; Interferon; Sarcoidosis

Indexed keywords

REBETRON;

ADULT; ARTICLE; BIOCHEMISTRY; CASE REPORT; CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DOSE TIME EFFECT RELATION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA NODOSUM; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MUSCLE WEAKNESS; PATHOGENESIS; PRIORITY JOURNAL; PUBLICATION; SARCOIDOSIS; TRANSBRONCHIAL BIOPSY;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; RIBAVIRIN; SARCOIDOSIS, PULMONARY;

EID: 0037285853     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021759120428     Document Type: Article

References (17)

1. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha. N Engl J Med 321:1501-1506, 1989
2. Teragawa H, Hondo T, Takahashi K, Watanabe H, Ohe H, Hattori N, Watanabe Y, Amano H, Hino F, Ohbayashi M, Urushihara T, Yonehara S: Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 35:19-23, 1996
3. Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T: Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 35:376-379, 1996
4. Hoffmann RM, Jung MC, Motz R, Gossl C, Emslander HP, Zachoval R, Pape GR: Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol; 28:1058-1063, 1998
5. Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K: Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest 105:939-941, 1994
6. Yufu Y, Yamashita S, Nishimura J, Nawata H, Hirata J: Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia. Am J Hematol 47:253, 1994
7. Vander Els NJ, Gerdes H: Sarcoidosis and IFN-alpha treatment. Chest 117:294, 2000.
8. Berlein-Konig BE, Hein R, Abeck D, Eengst R, Ring J: Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C. Br J Dermatol 140:370-372, 1999
9. Schmuth M, Prior C, Illersperger B, Topar G, Fritsch P, Sepp N: Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous? Br J Dermatol 140:952-955, 1999
10. Pietropaoli A, Modrak J, Utell M: Interferon-alpha therapy associated with the development of sarcoidosis. Chest 116:569-572, 1999
11. Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 308:793-800, 1983
12. Robinson BW, McLemore TL, Crystal RG: Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 75:1488-1495, 1985
13. Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ: Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59:896-900, 1987
14. Luers C, Sudhop T, Spengler U, Berthold HK: Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection. J Hepatol 30:347, 1999
15. Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 345:41-52, 2001
16. Malnick SD, Beergabel M, Lurie Y: Treatment of chronic hepatitis C virus infection. Ann Phramacother 34:1156-1164, 2000
17. Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G: Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 160:3487-3493, 1998